Overview
These awards address translational basic discovery activities (biological, social, behavioral mechanisms that underlie disease); development of biomarkers, target and lead molecules, and devices (mechanical, computational); preclinical and animal models; and translation of discovery to patients (new diagnostic, treatment, and prevention methods; Phase 1 and Phase 2 clinical trials).
Pilot applications MUST have two PIs from different scientific disciplines. Applicants will need to provide justification/evidence the PI team meets this qualification. Differences will also be inferred from areas of specialization and (or) degree training or departmental affiliation.
This opportunity is not currently accepting applications, but anticipates releasing a new RFA in early March 2025; please check back for details.
Projects Funded in 2023 (Word document)
